Back to Search
Start Over
Prospective monitoring of immune signatures in newly diagnosed high risk multiple myeloma patients under treatment with Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd): First results of the GMMG-CONCEPT trial.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; Oct2019 Supplement, Vol. 19, pe141-e142, 2p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 19
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 139237793
- Full Text :
- https://doi.org/10.1016/j.clml.2019.09.236